BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6274112)

  • 1. Ultrastructural modifications of the erythrocyte membrane in Down's syndrome.
    Kedziora J; Koter M; Bartel H; Bartosz G; Leyko W; Jeske J
    Acta Biol Med Ger; 1981; 40(4-5):423-8. PubMed ID: 6274112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging of the erythrocyte. IV. Spin-label studies of membrane lipids, proteins and permeability.
    Bartosz G
    Biochim Biophys Acta; 1981 Jun; 644(1):69-73. PubMed ID: 6266465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte anomalies in Down's syndrome.
    Bartosz G; Kedziora J
    Med Hypotheses; 1983 Aug; 11(4):471-7. PubMed ID: 6226851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive muscular dystrophy type Duchenne. I. Spin label studies on the physico-chemical state of erythrocyte membranes.
    Dellantonio R; Capriotti M; Di Bella P; Angeleri F; Bertoli E; Curatola G; Lenaz G
    Boll Soc Ital Biol Sper; 1979 Jun; 55(11):1021-7. PubMed ID: 232983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte glycohydrolases in subjects with trisomy 21: could Down's syndrome be a model of accelerated ageing?
    Massaccesi L; Corsi MM; Baquero-Herrera CJ; Licastro F; Tringali C; Venerando B; Lombardo A; Alberghino A; Goi G
    Mech Ageing Dev; 2006 Apr; 127(4):324-31. PubMed ID: 16460783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular organization of erythrocyte membranes in Duchenne muscular dystrophy].
    Falcioni AM; Ferretti G; Mazzanti L; Curatola G
    Boll Soc Ital Biol Sper; 1981 Dec; 57(23):2307-12. PubMed ID: 6279127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in red blood cell membrane structure in patients with chronic renal failure.
    Gwoździński K; Janicka M; Brzeszczyńska J; Luciak M
    Acta Biochim Pol; 1997; 44(1):99-107. PubMed ID: 9241360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The physiological significance of oxidative perturbations in erythrocyte membrane lipids and proteins.
    Hochstein P; Jain SK; Rice-Evans C
    Prog Clin Biol Res; 1981; 55():449-65. PubMed ID: 7291197
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of the orientation of a band 3 affinity spin-label relative to the membrane normal axis of the human erythrocyte.
    Hustedt EJ; Beth AH
    Biochemistry; 1996 May; 35(21):6944-54. PubMed ID: 8639646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of some radiosensitizing drugs on human erythrocyte membrane--spin label study.
    Mishra KP
    Indian J Biochem Biophys; 1982 Feb; 19(1):21-6. PubMed ID: 6286465
    [No Abstract]   [Full Text] [Related]  

  • 11. [Structural changes in erythrocyte membranes in nephropathy].
    Panasenko OM; Shalina RI; Azizova OA
    Biull Eksp Biol Med; 1985 Apr; 99(4):434-7. PubMed ID: 2985155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell glucose metabolism in Down's syndrome.
    Magnani M; Stocchi V; Novelli G; Dachà M; Fornaini G
    Clin Physiol Biochem; 1987; 5(1):9-14. PubMed ID: 2953518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging of the erythrocyte. VI. Accelerated red cell membrane aging in Down's syndrome?
    Bartosz G; Soszyński M; Kedziora J
    Cell Biol Int Rep; 1982 Jan; 6(1):73-7. PubMed ID: 6459857
    [No Abstract]   [Full Text] [Related]  

  • 14. Electron spin resonance study of the erythrocyte membrane fluidity changes in diabetes.
    Preoteasa EA; Ionescu-Tîrgovişte C; Grecu VV; Georgescu R
    Rom J Intern Med; 1993; 31(4):271-82. PubMed ID: 8148779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of altered aspartyl residues in erythrocyte proteins from patients with Down's syndrome.
    Galletti P; De Bonis ML; Sorrentino A; Raimo M; D'Angelo S; Scala I; Andria G; D'Aniello A; Ingrosso D; Zappia V
    FEBS J; 2007 Oct; 274(20):5263-77. PubMed ID: 17892495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipid content in erythrocyte membranes in patients with Down's syndrome].
    Shvarts EI; Rezenberg OA
    Pediatriia; 1976 Nov; (11):68-70. PubMed ID: 136633
    [No Abstract]   [Full Text] [Related]  

  • 17. Leucocyte ultrastructure and folate metabolism in Down's syndrome.
    Gericke GS; Hesseling PB; Brink S; Tiedt FC
    S Afr Med J; 1977 Mar; 51(12):369-74. PubMed ID: 139696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chlorpromazine on proteins in human erythrocyte membranes as inferred from spin labeling and biochemical analyses.
    Benga G; Ionescu M; Popescu O; Pop VI
    Mol Pharmacol; 1983 May; 23(3):771-8. PubMed ID: 6306435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the structural organization of the surface of lipoproteins and biological membranes].
    Panasenko OM; Borin ML; Azizova OA
    Izv Akad Nauk SSSR Biol; 1987; (6):837-46. PubMed ID: 2828445
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythrocyte membrane alterations in Huntington disease: effects of gamma-aminobutyric acid.
    Butterfield DA; Braden ML; Markesbery WR
    J Supramol Struct; 1978; 9(1):125-30. PubMed ID: 215837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.